Literature DB >> 23538073

Omega-3 fatty acids in psychiatry.

David Mischoulon1, Marlene P Freeman.   

Abstract

Over the past 2 decades, omega-3 fatty acids (n-3FAs) have been increasingly used and studied in the United States and worldwide for various medical and psychiatric indications. Numerous published clinical trials have examined applications of different n-3FA preparations, primarily in mood disorders but also in psychotic disorders, attention-deficit disorder, obsessive-compulsive disorder, and personality disorders. Focusing on clinical issues, this article reviews the impact of n-3FAs on these conditions and covers the relevant research, side effects, dosage guidelines, and drug interactions; clinicians should thus be able to better advise patients who are already taking n-3FAs or are interested in trying them.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23538073     DOI: 10.1016/j.psc.2012.12.002

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  21 in total

1.  Food, mood, and brain health: implications for the modern clinician.

Authors:  Laura Lachance; Drew Ramsey
Journal:  Mo Med       Date:  2015 Mar-Apr

2.  A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease.

Authors:  Robert M Carney; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; Brian C Steinmeyer; William S Harris
Journal:  J Clin Psychiatry       Date:  2019-06-04       Impact factor: 4.384

Review 3.  [Nutrition and dietary supplements in psychiatric diseases].

Authors:  H Himmerich; F Erbguth
Journal:  Nervenarzt       Date:  2014-12       Impact factor: 1.214

4.  Prevention of depression through nutritional strategies in high-risk persons: rationale and design of the MooDFOOD prevention trial.

Authors:  Miquel Roca; Elisabeth Kohls; Margalida Gili; Ed Watkins; Matthew Owens; Ulrich Hegerl; Gerard van Grootheest; Mariska Bot; Mieke Cabout; Ingeborg A Brouwer; Marjolein Visser; Brenda W Penninx
Journal:  BMC Psychiatry       Date:  2016-06-08       Impact factor: 3.630

Review 5.  N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology.

Authors:  Matteo M Pusceddu; Philip Kelly; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Int J Neuropsychopharmacol       Date:  2016-12-30       Impact factor: 5.176

Review 6.  The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD.

Authors:  Carlo Agostoni; Maria Nobile; Valentina Ciappolino; Giuseppe Delvecchio; Alessandra Tesei; Stefano Turolo; Alessandro Crippa; Alessandra Mazzocchi; Carlo A Altamura; Paolo Brambilla
Journal:  Int J Mol Sci       Date:  2017-12-04       Impact factor: 5.923

Review 7.  N-3 Polyunsatured Fatty Acids in Menopausal Transition: A Systematic Review of Depressive and Cognitive Disorders with Accompanying Vasomotor Symptoms.

Authors:  Valentina Ciappolino; Alessandra Mazzocchi; Paolo Enrico; Marie-Louise Syrén; Giuseppe Delvecchio; Carlo Agostoni; Paolo Brambilla
Journal:  Int J Mol Sci       Date:  2018-06-23       Impact factor: 5.923

Review 8.  The Management of Prodromal Symptoms of Bipolar Disorder: Available Options and Future Perspectives.

Authors:  Elisa Del Favero; Cristiana Montemagni; Paola Bozzatello; Claudio Brasso; Cecilia Riccardi; Paola Rocca
Journal:  Medicina (Kaunas)       Date:  2021-05-28       Impact factor: 2.430

9.  Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders.

Authors:  Kuan-Pin Su; Yutaka Matsuoka; Chi-Un Pae
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-08-31       Impact factor: 2.582

10.  Insomnia and exacerbation of anxiety associated with high-EPA fish oil supplements after successful treatment of depression.

Authors:  Lauren B Blanchard; Gordon C McCarter
Journal:  Oxf Med Case Reports       Date:  2015-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.